Christopher Ennen

Initiation or continuation of oral labetalol versus extended‐release nifedipine in expectant management of preeclampsia with severe features

Abstract Introduction Preeclampsia with severe features remains a major contributor to maternal and neonatal morbidity. In select patients <34 weeks, expectant management may safely prolong pregnancy and improve neonatal outcomes. Oral labetalol and extended‐release nifedipine...